Literature DB >> 15636438

Is ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome?

S Palomba1, F Orio, T Russo, A Falbo, T Cascella, A Colao, G Lombardi, F Zullo.   

Abstract

Polycystic ovary syndrome (PCOS) is one of the most common endocrine diseases affecting women of fertile age, and is characterized by hyperandrogenism, chronic anovulatory cycles and oligomenorrhea or amenorrhea. Given the repercussions of chronic anovulation on sterility, PCOS is a heavy social burden. Here we describe the procedures used to induce ovulation in PCOS patients, the surgical approach and medical treatments that are still being experimented.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15636438     DOI： 10.1007/BF03347527

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


  125 in total

Review 1.  Mechanism and inhibition of cytochrome P-450 aromatase.

Authors:  P A Cole; C H Robinson
Journal:  J Med Chem       Date:  1990-11       Impact factor: 7.446

2.  Improved responsiveness of PCOS patients to clomiphene after CYP17a inhibitor.

Authors:  H Ali Hassan; D El-Gezeiry; T M Nafaa; I Baghdady
Journal:  J Assist Reprod Genet       Date:  2001-11       Impact factor: 3.412

Review 3.  Polycystic ovary syndrome: a changing perspective.

Authors:  S Franks
Journal:  Clin Endocrinol (Oxf)       Date:  1989-07       Impact factor: 3.478

4.  Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome.

Authors:  Ghina Ghazeeri; William H Kutteh; Michael Bryer-Ash; Derek Haas; Raymond W Ke
Journal:  Fertil Steril       Date:  2003-03       Impact factor: 7.329

Review 5.  Polycystic ovary syndrome.

Authors:  S Franks
Journal:  N Engl J Med       Date:  1995-09-28       Impact factor: 91.245

Review 6.  Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome.

Authors:  E Hughes; J Collins; P Vandekerckhove
Journal:  Cochrane Database Syst Rev       Date:  2000

7.  Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome.

Authors:  E Papaleo; N Doldi; L De Santis; G Marelli; E Marsiglio; S Rofena; A Ferrari
Journal:  Hum Reprod       Date:  2001-11       Impact factor: 6.918

8.  A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.

Authors:  Mohammad Ebrahim Parsanezhad; Saeed Alborzi; Bahia Namavar Jahromi
Journal:  Int J Fertil Womens Med       Date:  2002 Nov-Dec

9.  Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome.

Authors:  L J Moran; M Noakes; P M Clifton; L Tomlinson; C Galletly; R J Norman
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

10.  The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study.

Authors:  Francesco Orio; Stefano Palomba; Letizia Spinelli; Teresa Cascella; Libuse Tauchmanovà; Fulvio Zullo; Gaetano Lombardi; Annamaria Colao
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958
View more
  3 in total

1.  Commonly used fertility drugs, a diet supplement, and stress force AMPK-dependent block of stemness and development in cultured mammalian embryos.

Authors:  Alan Bolnick; Mohammed Abdulhasan; Brian Kilburn; Yufen Xie; Mindie Howard; Paul Andresen; Alexandra M Shamir; Jing Dai; Elizabeth E Puscheck; Daniel A Rappolee
Journal:  J Assist Reprod Genet       Date:  2016-05-26       Impact factor: 3.412

2.  Altered Circulating Inflammatory Cytokines Are Associated with Anovulatory Polycystic Ovary Syndrome (PCOS) Women Resistant to Clomiphene Citrate Treatment.

Authors:  LianLian Wang; HongBo Qi; Philip N Baker; QianNa Zhen; Qing Zeng; Rui Shi; Chao Tong; Qian Ge
Journal:  Med Sci Monit       Date:  2017-03-01

3.  The Improvement Effect of D-Chiro-Inositol and Ecklonia cava K. in the Rat Model of Polycystic Ovarian Syndrome.

Authors:  Hyun Yang; Sang R Lee; Seong Lae Jo; Ae-Hyang Kim; Eun-Ryoung Kim; Fan Qu; Eui-Ju Hong; Hye Won Lee
Journal:  Front Pharmacol       Date:  2022-07-19       Impact factor: 5.988
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.